Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring

G Barabona, M Mahiti, S Masoud… - Journal of …, 2019 - academic.oup.com
Objectives We investigated the prevalence and patterns of pre-treatment and acquired HIV
drug resistance mutations (DRMs) in Tanzania as a 'treat all'strategy, virological monitoring …

[PDF][PDF] Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring

G Barabona, M Mahiti, S Masoud, P Mbelele… - researchgate.net
Objectives: We investigated the prevalence and patterns of pre-treatment and acquired HIV
drug resistance mutations (DRMs) in Tanzania as a 'treat all'strategy, virological monitoring …

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring.

G Barabona, M Mahiti, S Masoud, P Mbelele… - 2019 - cabidigitallibrary.org
Objectives: We investigated the prevalence and patterns of pre-treatment and acquired HIV
drug resistance mutations (DRMs) in Tanzania as a'treat all'strategy, virological monitoring …

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring

G Barabona, M Mahiti, S Masoud… - Journal of …, 2019 - academic.oup.com
Objectives We investigated the prevalence and patterns of pre-treatment and acquired HIV
drug resistance mutations (DRMs) in Tanzania as a 'treat all'strategy, virological monitoring …

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring

G Barabona, M Mahiti, S Masoud… - The Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives We investigated the prevalence and patterns of pre-treatment and acquired HIV
drug resistance mutations (DRMs) in Tanzania as a'treat all'strategy, virological monitoring …

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring.

G Barabona, M Mahiti, S Masoud… - The Journal of …, 2019 - europepmc.org
OBJECTIVES: We investigated the prevalence and patterns of pre-treatment and acquired
HIV drug resistance mutations (DRMs) in Tanzania as a'treat all'strategy, virological …

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring

G Barabona, M Mahiti, S Masoud, P Mbelele… - Journal of Antimicrobial …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objectives</jats: title>< jats: p>
We investigated the prevalence and patterns of pre-treatment and acquired HIV drug …